OMERS Administration Corp’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-108,976
Closed -$2.36M 1162
2025
Q4
$2.36M Buy
108,976
+14,176
+15% +$280K 0.02% 362
2025
Q3
$1.43M Hold
94,800
0.01% 488
2025
Q2
$1.07M Buy
94,800
+44,000
+87% +$477K 0.01% 498
2025
Q1
$513K Hold
50,800
﹤0.01% 728
2024
Q4
$601K Sell
50,800
-50,800
-50% -$601K 0.01% 657
2024
Q3
$1.17M Sell
101,600
-62,500
-38% -$712K 0.01% 490
2024
Q2
$1.73M Buy
+164,100
New +$1.8M 0.02% 421

Other funds holding ROIV

OMERS Administration Corp's ROIV Position: Q1 2026 in Review

OMERS Administration Corp sold out of Roivant Sciences (ROIV) in Q1 2026, closing a stake of 108,976 shares — an estimated $2.36M sold.

OMERS Administration Corp first reported a position in ROIV in Q2 2024 and held it in 7 quarters. The position peaked at $2.36M in Q4 2025. 444 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • OMERS Administration Corp reported no remaining Roivant Sciences position as of Q1 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 108,976 Roivant Sciences shares in Q1 2026, an estimated $2.36M.
  • OMERS Administration Corp first reported a position in Roivant Sciences in Q2 2024 and held it in 7 quarters.
  • OMERS Administration Corp's Roivant Sciences position peaked at $2.36M in Q4 2025.
  • 444 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.